179 million Europeans are currently living with brain disorders and this is to steadily increase as the population ages. Though one in three Europeans are set to live with a brain disease at some point of their life, neurological and mental alike. In addition, it is estimated that brain disorders account for up to 45% of total healthcare budgets and this burden is expected to grow.
Despite the prevalence of brain disorders in Europe, there is currently no disease modifying treatment available to cure a wide range of mental and neurological conditions. Developing treatments that can significantly improve the lives of those living with brain disorders is extremely challenging.
Yet, compared to other disease areas, the pace of innovation in this field has traditionally been hindered by multiple factors, including the complexity of the brain itself. As a result, brain treatments remain insufficient and research is disproportionately underfunded compared to other disease areas. We believe enhanced multi-stakeholder engagement in the brain ecosystem is needed to foster dialogue, exchange knowledge, accelerate investment in research and innovation, facilitate business development and showcase on-going work.
Visit & follow the #BIDays Social Media Channels: